Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,265.00
Bid: 2,255.00
Ask: 2,270.00
Change: 10.00 (0.44%)
Spread: 15.00 (0.665%)
Open: 2,255.00
High: 2,290.00
Low: 2,240.00
Prev. Close: 2,255.00
MGNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

14 Aug 2018 07:00

RNS Number : 6648X
Morgan Sindall Group PLC
14 August 2018
 
Morgan Sindall Group plc

 

14 August 2018

 

Morgan Sindall appoints David Lowden as a non-executive director

 

Morgan Sindall Group plc is pleased to announce the appointment of David Lowden as a non-executive director, with effect from 10 September 2018. David will be a member of the remuneration, nomination and audit committees.

 

David is a highly experienced Non-executive Director, Senior Independent Director and Chairman of UK listed companies. David is currently chair of the Board of FTSE 250 PageGroup having previously chaired the Remuneration Committee for three years. He is also chair of the audit & risk committee at William Hill and recently stepped down as SID from the Board of Berendsen. David was formerly Chief Executive of Taylor Nelson Sofres plc, having initially joined as Group Finance Director in 1999. David has spent his career working for a number of companies in senior finance roles, including as Group Finance Director at Asprey plc prior to joining Taylor Nelson Sofres. As a CFO as well as CEO, he has supported growth and profitability through the efficient design of business operations and appropriate use of systems and processes.

 

Commenting on the appointment, Michael Findlay, chairman of Morgan Sindall Group plc, said:

 

"We are delighted to welcome David to the Board. His extensive experience as both an executive and non-executive director of various successful companies will bring valuable knowledge and insight to Board discussions. I look forward to working with David in the coming years."

 

Ends

Notes to Editors:

There are no other details requiring disclosure under Listing Rule 9.6.13 in relation to David Lowden.

 

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of c£2.8 billion and which operates through six divisions of Construction & Infrastructure, Fit Out, Property Services, Partnership Housing, Urban Regeneration and Investments.

 

ENQUIRIES:

Morgan Sindall Group plc

Tel: 07816 958187

Michael Findlay, Chair

Instinctif Partners (Financial PR)

Tel: 020 7457 2020

MorganSindall@instinctif.com

 

Matthew Smallwood

 

Tel: 07831 379 122

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLGDICGBBGIX
Date   Source Headline
1st May 202010:54 amRNSTotal Voting Rights
1st May 202010:37 amRNSChange in Director's details
27th Apr 202010:40 amRNSDisclosure of rights attached to equity shares
20th Apr 20201:10 pmRNSBlock listing Interim Review
2nd Apr 20202:57 pmRNSAnnual Financial Report
1st Apr 202012:08 pmRNSTotal Voting Rights
25th Mar 20207:00 amRNSCOVID-19 Update
11th Mar 20203:45 pmRNSHolding(s) in Company
11th Mar 20208:30 amRNSAdditional Listing
9th Mar 20202:33 pmRNSHolding(s) in Company
9th Mar 20202:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20202:14 pmRNSHolding(s) in Company
2nd Mar 20204:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSTotal Voting Rights
27th Feb 20202:02 pmRNSHolding(s) in Company
27th Feb 20201:48 pmRNSHolding(s) in Company
27th Feb 20201:39 pmRNSHolding(s) in Company
27th Feb 202010:35 amRNSDirector/PDMR Shareholding
24th Feb 20205:45 pmRNSSophos Group
20th Feb 20207:00 amRNSFinal Results
3rd Feb 20204:20 pmRNSTotal Voting Rights
31st Jan 20203:44 pmRNSHolding(s) in Company
29th Jan 20204:18 pmRNSHolding(s) in Company
24th Jan 20203:25 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSDirectorate Change
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing
18th Nov 20199:48 amRNSAppointment to c£650m Slough scheme
18th Nov 20197:00 amRNSSenior Management Forum
11th Nov 201912:05 pmRNSHolding(s) in Company
11th Nov 201910:25 amRNSDirector/PDMR Shareholding
6th Nov 20197:00 amRNSTrading Update
1st Nov 20191:58 pmRNSTotal Voting Rights
21st Oct 201910:07 amRNSBlock listing Interim Review
8th Oct 20194:37 pmRNSPrice Monitoring Extension
2nd Oct 20194:08 pmRNSHolding(s) in Company
1st Oct 201910:19 amRNSTotal Voting Rights
3rd Sep 201911:30 amRNSAdditional Listing
2nd Sep 20192:49 pmRNSTotal Voting Rights
13th Aug 20193:34 pmRNSHolding(s) in Company
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 201910:08 amRNSTotal Voting Rights
30th Jul 20194:44 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSNotice of Results
1st Jul 201910:20 amRNSTotal Voting Rights
24th Jun 20194:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.